STOCK TITAN

[144] KEWAUNEE SCIENTIFIC CORP /DE/ SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Form 144 notice by an insider of Kewaunee Scientific Corp (KEQU) discloses a proposed sale of 1,000 common shares through Fidelity Brokerage Services (Boston) with an aggregate market value of $42,720, and lists prior open-market sales by the same person totaling 5,000 shares across five transactions between September 18–29, 2025, generating gross proceeds shown for each trade. The 1,000 shares were acquired as a stock award on June 30, 2024 and were issued as compensation. The filer certifies they are not aware of undisclosed material adverse information about the issuer.

Il modulo 144, rivelato da un insider di Kewaunee Scientific Corp (KEQU) annuncia una vendita proposta di 1.000 azioni comuni attraverso Fidelity Brokerage Services (Boston) con un valore di mercato complessivo di $42,720, e indica vendite precedenti sul mercato aperto effettuate dalla stessa persona per un totale di 5.000 azioni in cinque operazioni tra il 18 e il 29 settembre 2025, generando proventi lordi indicati per ogni operazione. Le 1.000 azioni sono state acquisite come premio azionario il 30 giugno 2024 e sono state emesse come compenso. Il firmatario certifica di non essere a conoscenza di informazioni materialmente avverse non divulgate sull'emittente.

El aviso Formulario 144 de un insider de Kewaunee Scientific Corp (KEQU) revela una venta propuesta de 1,000 acciones ordinarias a través de Fidelity Brokerage Services (Boston) con un valor de mercado agregado de $42,720, y enumera ventas previas en el mercado abierto realizadas por la misma persona que suman un total de 5,000 acciones en cinco transacciones entre el 18 y el 29 de septiembre de 2025, generando los ingresos brutos indicados para cada operación. Las 1,000 acciones fueron adquiridas como una prima de acciones el 30 de junio de 2024 y se emitieron como compensación. El declarante certifica que no tiene conocimiento de información material adversa no divulgada sobre el emisor.

Kewaunee Scientific Corp(KEQU) 내부자의 Form 144 공지는 Fidelity Brokerage Services(Boston)를 통해 1,000주 보통주 매각을 제안하며 총 시장가치는 $42,720이고, 같은 사람이 2025년 9월 18일~29일 사이 다섯 건의 거래로 5,000주를 오픈 마켓에서 매도한 이전 거래를 나열하며 각 거래에 대한 매출 총액이 표시된다. 이 1,000주는 2024년 6월 30일에 주식 보상으로 취득되었고 보상으로 발행되었다. 신고자는 발행자에 대해 비공개로 공표되지 않은 중요한 불리한 정보가 없다고 certify한다.

L’avis Form 144 d’un initié de Kewaunee Scientific Corp (KEQU) révèle une vente proposée de 1 000 actions ordinaires par Fidelity Brokerage Services (Boston) d’une valeur marchande globale de 42 720 $, et répertorie des ventes antérieures sur le marché libre par la même personne totalisant 5 000 actions à travers cinq transactions entre le 18 et le 29 septembre 2025, générant des produits bruts indiqués pour chaque opération. Les 1 000 actions ont été acquises en tant que rémunération en actions le 30 juin 2024 et ont été émises comme compensation. Le déposant certifie qu’il n’a pas connaissance d’informations négatives significatives non divulguées concernant l’émetteur.

Hinweis Formular 144 eines Insiders der Kewaunee Scientific Corp (KEQU) offenbart einen vorgeschlagenen Verkauf von 1.000 Stammaktien über Fidelity Brokerage Services (Boston) mit einem Gesamtsmarktwert von $42,720 und führt frühere Verkäufe am offenen Markt durch dieselbe Person in insgesamt 5.000 Aktien in fünf Transaktionen zwischen dem 18. und 29. September 2025 auf, wobei die Bruttoerlöse für jeden Handel angegeben sind. Die 1.000 Aktien wurden am 30. Juni 2024 im Rahmen eines Aktienprämienprogramms erworben und als Vergütung ausgegeben. Der Einreicher versichert, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten bekannt sind.

إشعار النموذج 144 من مصدر داخلي في شركة Kewaunee Scientific Corp (KEQU) يكشف عن اقتراح بيع لـ 1,000 سهم عادي من خلال Fidelity Brokerage Services (Boston) بقيمة سوقية إجمالية قدرها $42,720، ويستعرض مبيعات سابقة في السوق المفتوح من قبل نفس الشخص بإجمالي 5,000 سهم عبر خمس معاملات بين 18 و29 سبتمبر 2025، مع إيرادات إجمالية مبينة لكل صفقة. تم الحصول على الـ1,000 سهم كجائزة أسهم في 30 يونيو 2024 وأصدرت كمكافأة. يؤكد المُقدم أنه لا يعلم بوجود معلومات سلبية جوهرية غير مُعلنة عن المصدر.

基瓦尼科学公司(KEQU)内部人Form 144通知披露通过Fidelity Brokerage Services(Boston)拟出售1,000股普通股,市值合计为$42,720,并列出同一人此前在公开市场上的5,000股分五笔交易的销售,总交易额如各笔交易所示。此1,000股是于2024年6月30日作为股票奖励取得,作为报酬发行。申报人证明他不知悉有关发行人的未披露的重要不利信息。

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine Rule 144 notice reporting a proposed sale of stock-awarded shares and recent small open-market dispositions by an insider.

This Form 144 documents a prospective sale of 1,000 common shares acquired as a stock award on 06/30/2024, to be executed via Fidelity with an indicated market value of $42,720 and an approximate sale date of 09/30/2025. The filing also lists five recent sales by the same individual totaling 5,000 shares during 09/18–09/29/2025 with reported gross proceeds per trade. From an investor-materiality perspective, these disclosures are procedural under Rule 144 and provide transparency about insider liquidity but do not by themselves indicate company performance or new material events.

TL;DR: Compliance-focused disclosure showing insider is selling previously awarded shares and affirming absence of undisclosed material information.

The notice shows adherence to Rule 144 reporting requirements: the securities were acquired as compensation and the filer attests no undisclosed material adverse information exists. The recent sequence of small sales over several days suggests staged disposition consistent with volume-limited insider sales rather than a single large block sale. This filing is governance-compliant and signals routine insider liquidity rather than governance concerns based solely on the disclosed facts.

Il modulo 144, rivelato da un insider di Kewaunee Scientific Corp (KEQU) annuncia una vendita proposta di 1.000 azioni comuni attraverso Fidelity Brokerage Services (Boston) con un valore di mercato complessivo di $42,720, e indica vendite precedenti sul mercato aperto effettuate dalla stessa persona per un totale di 5.000 azioni in cinque operazioni tra il 18 e il 29 settembre 2025, generando proventi lordi indicati per ogni operazione. Le 1.000 azioni sono state acquisite come premio azionario il 30 giugno 2024 e sono state emesse come compenso. Il firmatario certifica di non essere a conoscenza di informazioni materialmente avverse non divulgate sull'emittente.

El aviso Formulario 144 de un insider de Kewaunee Scientific Corp (KEQU) revela una venta propuesta de 1,000 acciones ordinarias a través de Fidelity Brokerage Services (Boston) con un valor de mercado agregado de $42,720, y enumera ventas previas en el mercado abierto realizadas por la misma persona que suman un total de 5,000 acciones en cinco transacciones entre el 18 y el 29 de septiembre de 2025, generando los ingresos brutos indicados para cada operación. Las 1,000 acciones fueron adquiridas como una prima de acciones el 30 de junio de 2024 y se emitieron como compensación. El declarante certifica que no tiene conocimiento de información material adversa no divulgada sobre el emisor.

Kewaunee Scientific Corp(KEQU) 내부자의 Form 144 공지는 Fidelity Brokerage Services(Boston)를 통해 1,000주 보통주 매각을 제안하며 총 시장가치는 $42,720이고, 같은 사람이 2025년 9월 18일~29일 사이 다섯 건의 거래로 5,000주를 오픈 마켓에서 매도한 이전 거래를 나열하며 각 거래에 대한 매출 총액이 표시된다. 이 1,000주는 2024년 6월 30일에 주식 보상으로 취득되었고 보상으로 발행되었다. 신고자는 발행자에 대해 비공개로 공표되지 않은 중요한 불리한 정보가 없다고 certify한다.

L’avis Form 144 d’un initié de Kewaunee Scientific Corp (KEQU) révèle une vente proposée de 1 000 actions ordinaires par Fidelity Brokerage Services (Boston) d’une valeur marchande globale de 42 720 $, et répertorie des ventes antérieures sur le marché libre par la même personne totalisant 5 000 actions à travers cinq transactions entre le 18 et le 29 septembre 2025, générant des produits bruts indiqués pour chaque opération. Les 1 000 actions ont été acquises en tant que rémunération en actions le 30 juin 2024 et ont été émises comme compensation. Le déposant certifie qu’il n’a pas connaissance d’informations négatives significatives non divulguées concernant l’émetteur.

Hinweis Formular 144 eines Insiders der Kewaunee Scientific Corp (KEQU) offenbart einen vorgeschlagenen Verkauf von 1.000 Stammaktien über Fidelity Brokerage Services (Boston) mit einem Gesamtsmarktwert von $42,720 und führt frühere Verkäufe am offenen Markt durch dieselbe Person in insgesamt 5.000 Aktien in fünf Transaktionen zwischen dem 18. und 29. September 2025 auf, wobei die Bruttoerlöse für jeden Handel angegeben sind. Die 1.000 Aktien wurden am 30. Juni 2024 im Rahmen eines Aktienprämienprogramms erworben und als Vergütung ausgegeben. Der Einreicher versichert, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen über den Emittenten bekannt sind.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the KEQU Form 144 disclose about the proposed sale?

The notice discloses a proposed sale of 1,000 common shares via Fidelity Brokerage with an aggregate market value of $42,720 and an approximate sale date of 09/30/2025.

How were the 1,000 shares to be sold acquired?

The shares were acquired as a stock award from the issuer on 06/30/2024 and were issued as compensation.

What recent insider sales does the filing list for the seller?

The filing lists five open-market sales by Thomas D. Hull III between 09/18/2025 and 09/29/2025 totaling 5,000 shares with reported gross proceeds for each trade.

Who is the broker handling the proposed sale?

The proposed sale is to be executed through Fidelity Brokerage Services LLC, located at 245 Summer Street, Boston, MA.

Does the filer assert knowledge of undisclosed material information?

Yes; by signing the notice the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.
Kewaunee Scienti

NASDAQ:KEQU

KEQU Rankings

KEQU Latest News

KEQU Latest SEC Filings

KEQU Stock Data

124.11M
2.13M
23.58%
39.02%
1.83%
Furnishings, Fixtures & Appliances
Laboratory Apparatus & Furniture
Link
United States
STATESVILLE